Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Penicillin-binding protein 5 (PBP5) is an enzyme involved in bacterial cell wall synthesis and remodeling. It functions primarily as a D-alanyl-D-alanine carboxypeptidase, regulating peptidoglycan cross-linking. In some species, PBP5 also exhibits beta-lactamase activity or low affinity for beta-lactam antibiotics, contributing to antibiotic resistance. It is found in Escherichia coli, Pseudomonas aeruginosa, and Enterococcus faecium, making it clinically relevant in the context of drug-resistant infections.
Inhibition of peptidoglycan cross-linking; hydrolysis of beta-lactam antibiotics (in some species)
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Penicillin-binding protein 5.